Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that patients with patchy alopecia areata had significantly higher serum levels of pro-inflammatory cytokines IL-6, TNF-α, IL-17A, and IL-21 compared to healthy controls, with these levels correlating positively with disease severity, age, and disease duration.

This paper contains author contact information and disclosures without reporting new research findings or results.

This report describes two cases of cutaneous lupus erythematosus mimicking alopecia areata, highlighting the importance of considering CLE in the diagnosis of patchy hair loss to prevent scarring alopecia.

This article discusses scalp dermatoscopy and home CI therapy as promising diagnostic and treatment options for alopecia areata but reports no new clinical results.

This case report describes how alopecia areata and Beau's lines resolved in a child following treatment for Kawasaki disease, suggesting these symptoms may be linked to the underlying autoimmune process.

This article reviews various treatment options for diseases associated with cicatricial alopecia but reports no new clinical results.

This article offers a question-by-question guide to assist clinicians in diagnosing hair shaft disorders, presenting no new clinical results.

This study found that intralesional injections of triamcinolone acetonide at 5 mg/mL are as effective and safe as 10 mg/mL for treating patchy alopecia areata on the scalp, with similar hair regrowth rates, side effects, and recurrence observed between the two dosages.

This retrospective cohort study found that individuals with alopecia totalis or universalis have a higher prevalence of systemic autoimmune diseases, particularly endocrine diseases and inflammatory bowel disease, compared to those with patchy alopecia areata.

This review highlights that nano-antioxidants show promise as a treatment strategy for immune-mediated inflammatory diseases, like autoimmune and chronic inflammatory conditions, due to their improved stability and targeted delivery, but notes that further research is necessary to optimize their use and assess long-term safety.

This article discusses vitiligo, reviewing its symptoms, possible causes, and classification, but reports no new clinical findings.

This review outlines various causes and manifestations of hair loss, highlighting that each type has distinct underlying mechanisms and requires specific treatment approaches, without reporting new clinical results.

This review discusses various hair disorders associated with autoimmune connective tissue diseases, particularly lupus erythematosus, and highlights diagnostic approaches but reports no new clinical results.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

In this study, patients with scalp seborrheic dermatitis exhibited distinct patterns of allergen sensitization tied to symptoms, impaired skin barrier, and altered microbiota, emphasizing the need to consider allergen exposure, barrier status, and microbial balance when interpreting patch test results.

This study found that, among patients in Ismailia, Egypt, patchy alopecia areata was the most common form, with a significant positive correlation between the number of lesions and disease severity, and noted males predominantly affected by this condition.

This study identified changes in immune activation, ferroptosis, and structural genes in alopecia areata subtypes, suggesting molecular markers that might help understand disease variability and guide future treatments.

This study found that tofacitinib led to ≥50% hair regrowth in eight out of twelve patients with moderate to severe alopecia areata, suggesting a potential benefit for using JAK inhibitors in treating this condition.

This review discusses the clinical presentations of alopecia areata, introduces guidelines for treatment studies, and explores potential changes in cutaneous innervation, but reports no new clinical results.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

In vivo using the C3H mouse model, this study observed that BST2 expression occurs before hair loss in alopecia areata and is followed by an increase in epidermal γδ T cell numbers.

This case report demonstrates successful treatment of Indralupta using Prachhana karma, Shirolepa, and Bhringarajadi Rasayana in Ayurvedic practice.

In this case study, a female patient with alopecia areata experienced significant symptom reduction after Ayurvedic treatments including Nasya and Pracchanna karma, suggesting potential effectiveness of this approach for managing autoimmune hair disorders.

In this case study, a female patient with alopecia areata experienced significant symptom reduction following Ayurvedic treatment, including Nasya and Pracchanna karma, suggesting potential benefits of Ayurveda for autoimmune hair disorders.

This study identified specific genes upregulated in skin γδ T cells involved in alopecia areata, with findings suggesting these cells contribute to disease pathogenesis through inflammatory and Th1 response mechanisms in mouse and possibly human skin.

This source explores the association between alopecia areata and thyroid dysfunction, highlighting a particularly strong link with Hashimoto thyroiditis and hypothyroidism.

This review discusses the role of diet and lifestyle in managing alopecia and reports no new clinical results.

This review discusses genetic and environmental factors contributing to autoimmunity in alopecia areata and reports no new clinical findings, emphasizing the need for further study on its aetiology and pathophysiology.

This review proposes a classification system for childhood hair loss based on clinical appearance, age of onset, and associated symptoms, but reports no new clinical results.

In this study, 62.7% of patients with alopecia areata had deficient vitamin D levels, yet there was no significant link between these levels and specific alopecia areata patterns.